Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,716

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

Aggarwal, Bharat B., Harikumar, Kuzhuvelil B.·2009·The International Journal of Biochemistry & Cell Biology
DOI 10.1016/j.biocel.2008.06.010
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biocel.2008.06.010

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 215

  1. Abdou, 2008, Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study, J Cutan Pathol, 35, 445, 10.1111/j.1600-0560.2007.00841.x · DOI
  2. Abe, 1999, Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages, Pharmacol Res, 39, 41, 10.1006/phrs.1998.0404 · DOI
  3. Aggarwal, 2004, Nuclear factor-kappaB: the enemy within, Cancer Cell, 6, 203, 10.1016/j.ccr.2004.09.003 · DOI
  4. Aggarwal, 1985, Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon, Nature, 318, 665, 10.1038/318665a0 · DOI
  5. Aggarwal, 1985, Human tumor necrosis factor. Production, purification, and characterization, J Biol Chem, 260, 2345, 10.1016/S0021-9258(18)89560-6 · DOI
  6. Aggarwal, 2007, Targeting cell signaling pathways for drug discovery: an old lock needs a new key, J Cell Biochem, 102, 580, 10.1002/jcb.21500 · DOI
  7. Aggarwal, 2006, Inflammation and cancer: how hot is the link?, Biochem Pharmacol, 72, 1605, 10.1016/j.bcp.2006.06.029 · DOI · Paper page
  8. Aggarwal, 2005, Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice, Clin Cancer Res, 11, 7490, 10.1158/1078-0432.CCR-05-1192 · DOI · Paper page
  9. Aggarwal, 2006, TNF blockade: an inflammatory issue, Ernst Schering Res Found Workshop, 161
  10. Aggarwal, 2006, Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation, Mol Pharmacol, 69, 195, 10.1124/mol.105.017400 · DOI · Paper page
  11. Aggarwal, 2004, Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling, Int J Cancer, 111, 679, 10.1002/ijc.20333 · DOI · Paper page
  12. Ahn, 2005, Transcription factor NF-kappaB: a sensor for smoke and stress signals, Ann N Y Acad Sci, 1056, 218, 10.1196/annals.1352.026 · DOI
  13. Al-Omar, 2006, Immediate and delayed treatments with curcumin prevents forebrain ischemia-induced neuronal damage and oxidative insult in the rat hippocampus, Neurochem Res, 31, 611, 10.1007/s11064-006-9059-1 · DOI
  14. Anand, 2008, Curcumin and cancer: an “old-age” disease with an “age-old” solution, Cancer Lett, 10.1016/j.canlet.2008.03.025 · DOI
  15. Annaert, 2002, A cell biological perspective on Alzheimer's disease, Annu Rev Cell Dev Biol, 18, 25, 10.1146/annurev.cellbio.18.020402.142302 · DOI · Paper page
  16. Ansell, 2007, Targeting the anti-inflammatory effects of high-density lipoprotein, Am J Cardiol, 100, n3, 10.1016/j.amjcard.2007.08.006 · DOI
  17. Aoki, 2007, Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways, Mol Pharmacol, 72, 29, 10.1124/mol.106.033167 · DOI
  18. Arun, 2002, Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats, Plant Foods Hum Nutr, 57, 41, 10.1023/A:1013106527829 · DOI
  19. Atamna, 2006, Amyloid-beta peptide binds with heme to form a peroxidase: relationship to the cytopathologies of Alzheimer's disease, Proc Natl Acad Sci USA, 103, 3381, 10.1073/pnas.0600134103 · DOI · Paper page
  20. Atwood, 2004, Copper mediates dityrosine cross-linking of Alzheimer's amyloid-beta, Biochemistry, 43, 560, 10.1021/bi0358824 · DOI · Paper page
  21. Babu, 1995, Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat, Mol Cell Biochem, 152, 13, 10.1007/BF01076459 · DOI
  22. Babu, 1997, Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats, Mol Cell Biochem, 166, 169, 10.1023/A:1006819605211 · DOI · Paper page
  23. Balasubramanyam, 2004, Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription, J Biol Chem, 279, 51163, 10.1074/jbc.M409024200 · DOI · Paper page
  24. Banerjee, 2003, Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat, Immunopharmacol Immunotoxicol, 25, 213, 10.1081/IPH-120020471 · DOI
  25. Barthelemy, 1998, Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type 1 human immunodeficiency virus long terminal repeat, Res Virol, 149, 43, 10.1016/S0923-2516(97)86899-9 · DOI
  26. Baum, 2008, Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease, J Clin Psychopharmacol, 28, 110, 10.1097/jcp.0b013e318160862c · DOI · Paper page
  27. Baum, 2004, Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models, J Alzheimers Dis, 6, 367, 10.3233/JAD-2004-6403 · DOI · Paper page
  28. Bayrak, 2008, Curcumin protects against ischemia/reperfusion injury in rat kidneys, World J Urol, 26, 285, 10.1007/s00345-008-0253-4 · DOI
  29. Best, 2007, Curcumin induces electrical activity in rat pancreatic beta-cells by activating the volume-regulated anion channel, Biochem Pharmacol, 73, 1768, 10.1016/j.bcp.2007.02.006 · DOI
  30. Bharti, 2003, Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells, J Immunol, 171, 3863, 10.4049/jimmunol.171.7.3863 · DOI · Paper page
  31. Bharti, 2003, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis, Blood, 101, 1053, 10.1182/blood-2002-05-1320 · DOI · Paper page
  32. Billerey-Larmonier, 2008, Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependent, Inflamm Bowel Dis, 14, 780, 10.1002/ibd.20348 · DOI
  33. Bishnoi, 2008, Protective effect of curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain, Pharmacol Biochem Behav, 88, 511, 10.1016/j.pbb.2007.10.009 · DOI
  34. Bisht, 2007, Polymeric nanoparticle-encapsulated curcumin (“nanocurcumin”): a novel strategy for human cancer therapy, J Nanobiotechnol, 5, 3, 10.1186/1477-3155-5-3 · DOI
  35. Biswas, 2008, Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin, Mol Nutr Food Res, 10.1002/mnfr.200700259 · DOI
  36. Calabrese, 2003, Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach, Amino Acids, 25, 437, 10.1007/s00726-003-0048-2 · DOI
  37. Chen, 2008, Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation, Health Technol Assess, 12, 1, 10.3310/hta12110 · DOI
  38. Chen, 2008, C-reactive protein increases plasminogen activator inhibitor-1 expression in human endothelial cells, Thromb Res, 122, 125, 10.1016/j.thromres.2007.09.006 · DOI
  39. Cheng, 2001, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions, Anticancer Res, 21, 2895
  40. Cruz-Correa, 2006, Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis, Clin Gastroenterol Hepatol, 4, 1035, 10.1016/j.cgh.2006.03.020 · DOI · Paper page
  41. Danese, 2008, Inflammatory bowel disease and inflammation-associated colon cancer: partners in crime, Curr Drug Targets, 9, 360, 10.2174/138945008784221134 · DOI
  42. Davis, 2007, Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage, Am J Physiol Regul Integr Comp Physiol, 292, R2168, 10.1152/ajpregu.00858.2006 · DOI
  43. Deeb, 2007, J Pharmacol Exp Ther, 321, 616, 10.1124/jpet.106.117721 · DOI
  44. Deguchi, 2007, Curcumin prevents the development of dextran sulfate Sodium (DSS)-induced experimental colitis, Dig Dis Sci, 52, 2993, 10.1007/s10620-006-9138-9 · DOI
  45. Deodhar, 1980, Preliminary study on antirheumatic activity of curcumin (diferuloyl methane), Indian J Med Res, 71, 632
  46. Dhillon, 2008, Phase II trial of curcumin, an NF-κB inhibitor, in patients with advanced pancreatic cancer, Clin Cancer Res, 14, 4491, 10.1158/1078-0432.CCR-08-0024 · DOI
  47. Fahey, 2007, Curcumin modulation of IFN-beta and IL-12 signalling and cytokine induction in human T cells, J Cell Mol Med, 11, 1129, 10.1111/j.1582-4934.2007.00089.x · DOI
  48. Farhangkhoee, 2006, Differential effects of curcumin on vasoactive factors in the diabetic rat heart, Nutr Metab (Lond), 3, 27, 10.1186/1743-7075-3-27 · DOI
  49. Feng, 2008, Regulation of cardiomyocyte hypertrophy in diabetes at the transcriptional level, Am J Physiol Endocrinol Metab, 10.1152/ajpendo.00029.2008 · DOI
  50. Fiala, 2007, Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin, Proc Natl Acad Sci USA, 104, 12849, 10.1073/pnas.0701267104 · DOI
  51. Funk, 2006, Turmeric extracts containing curcuminoids prevent experimental rheumatoid arthritis, J Nat Prod, 69, 351, 10.1021/np050327j · DOI
  52. Garcia-Alloza, 2007, Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model, J Neurochem, 102, 1095, 10.1111/j.1471-4159.2007.04613.x · DOI
  53. Garodia, 2007, From ancient medicine to modern medicine: ayurvedic concepts of health and their role in inflammation and cancer, J Soc Integr Oncol, 5, 25, 10.2310/7200.2006.029 · DOI
  54. Ghoneim, 2002, Protective effects of curcumin against ischaemia/reperfusion insult in rat forebrain, Pharmacol Res, 46, 273, 10.1016/S1043-6618(02)00123-8 · DOI
  55. Goel, 2008, Curcumin as “Curecumin”: from kitchen to clinic, Biochem Pharmacol, 75, 787, 10.1016/j.bcp.2007.08.016 · DOI
  56. Hafner-Bratkovic, 2008, Curcumin binds to the alpha-helical intermediate and to the amyloid form of prion protein—a new mechanism for the inhibition of PrP(Sc) accumulation, J Neurochem, 104, 1553, 10.1111/j.1471-4159.2007.05105.x · DOI
  57. Haidara, 2006, Role of oxidative stress in development of cardiovascular complications in diabetes mellitus, Curr Vasc Pharmacol, 4, 215, 10.2174/157016106777698469 · DOI
  58. Hak, 2008, Lifestyle and gout, Curr Opin Rheumatol, 20, 179, 10.1097/BOR.0b013e3282f524a2 · DOI
  59. Hansson, 2006, Inflammation and atherosclerosis, Annu Rev Pathol, 1, 297, 10.1146/annurev.pathol.1.110304.100100 · DOI · Paper page
  60. Heng, 2000, Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters, Br J Dermatol, 143, 937, 10.1046/j.1365-2133.2000.03767.x · DOI
  61. Hold, 2008, Genetic aspects of inflammation and cancer, Biochem J, 410, 225, 10.1042/BJ20071341 · DOI
  62. Holt, 2005, Curcumin therapy in inflammatory bowel disease: a pilot study, Dig Dis Sci, 50, 2191, 10.1007/s10620-005-3032-8 · DOI
  63. Hong, 2004, Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase, Carcinogenesis, 25, 1671, 10.1093/carcin/bgh165 · DOI
  64. Huang, 2004, Redox-active metals, oxidative stress, and Alzheimer's disease pathology, Ann N Y Acad Sci, 1012, 153, 10.1196/annals.1306.012 · DOI · Paper page
  65. Jackson, 2006, The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis, Inflamm Res, 55, 168, 10.1007/s00011-006-0067-z · DOI
  66. Jagetia, 2007, “Spicing up” of the immune system by curcumin, J Clin Immunol, 27, 19, 10.1007/s10875-006-9066-7 · DOI
  67. Jain, 2006, Effect of curcumin on protein glycosylation, lipid peroxidation, and oxygen radical generation in human red blood cells exposed to high glucose levels, Free Radic Biol Med, 41, 92, 10.1016/j.freeradbiomed.2006.03.008 · DOI
  68. Jess, 2005, Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies, Am J Gastroenterol, 100, 2724, 10.1111/j.1572-0241.2005.00287.x · DOI · Paper page
  69. Jian, 2005, Preventive and therapeutic effects of NF-kappaB inhibitor curcumin in rats colitis induced by trinitrobenzene sulfonic acid, World J Gastroenterol, 11, 1747, 10.3748/wjg.v11.i12.1747 · DOI
  70. Jiang, 2007, Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage, Eur J Pharmacol, 561, 54, 10.1016/j.ejphar.2006.12.028 · DOI
  71. Joe, 1997, Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin, Mol Cell Biochem, 169, 125, 10.1023/A:1006877928703 · DOI
  72. Jones, 2000, The effect of mycophenolate mofetil and polyphenolic bioflavonoids on renal ischemia reperfusion injury and repair, J Urol, 163, 999, 10.1016/S0022-5347(05)67871-8 · DOI
  73. Ju, 1996, Effects of dietary fats and curcumin on IgE-mediated degranulation of intestinal mast cells in brown Norway rats, Biosci Biotechnol Biochem, 60, 1856, 10.1271/bbb.60.1856 · DOI
  74. Kamat, 2007, Curcumin potentiates the apoptotic effects of chemotherapeutic agents and cytokines through down-regulation of nuclear factor-kappaB and nuclear factor-kappaB-regulated gene products in IFN-alpha-sensitive and IFN-alpha-resistant human bladder cancer cells, Mol Cancer Ther, 6, 1022, 10.1158/1535-7163.MCT-06-0545 · DOI
  75. Kanitkar, 2008, Curcumin treatment enhances islet recovery by induction of heat shock response proteins, Hsp70 and heme oxygenase-1, during cryopreservation, Life Sci, 82, 182, 10.1016/j.lfs.2007.10.026 · DOI
  76. Karin, 2005, NF-kappaB: linking inflammation and immunity to cancer development and progression, Nat Rev Immunol, 5, 749, 10.1038/nri1703 · DOI
  77. Kawanami, 2006, C-reactive protein induces VCAM-1 gene expression through NF-kappaB activation in vascular endothelial cells, Atherosclerosis, 185, 39, 10.1016/j.atherosclerosis.2005.01.057 · DOI
  78. Kean, 2005, The use of NSAIDs in rheumatic disorders 2005: a global perspective, Inflammopharmacology, 13, 343, 10.1163/156856005774415565 · DOI
  79. Khanna, 2007, Natural products as a gold mine for arthritis treatment, Curr Opin Pharmacol, 7, 344, 10.1016/j.coph.2007.03.002 · DOI · Paper page
  80. Kim, 2001, Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult, Neurosci Lett, 303, 57, 10.1016/S0304-3940(01)01677-9 · DOI
  81. Kobayashi, 1997, Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics, Biochem Pharmacol, 54, 819, 10.1016/S0006-2952(97)00220-7 · DOI
  82. Kowluru, 2007, Oxidative stress and diabetic retinopathy, Exp Diabetes Res, 2007, 43603, 10.1155/2007/43603 · DOI · Paper page
  83. Kowluru, 2007, Effects of curcumin on retinal oxidative stress and inflammation in diabetes, Nutr Metab (Lond), 4, 8, 10.1186/1743-7075-4-8 · DOI
  84. Kuhad, 2007, Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences, Eur J Pharmacol, 576, 34, 10.1016/j.ejphar.2007.08.001 · DOI
  85. Kumar, 2004, Nuclear factor-kappaB: its role in health and disease, J Mol Med, 82, 434, 10.1007/s00109-004-0555-y · DOI · Paper page
  86. Kumar, 2005, Elevated expression of alphaA- and alphaB-crystallins in streptozotocin-induced diabetic rat, Arch Biochem Biophys, 444, 77, 10.1016/j.abb.2005.09.021 · DOI
  87. Kunnumakkara, 2008, Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins, Cancer Lett, 10.1016/j.canlet.2008.03.009 · DOI · Paper page
  88. Kunnumakkara, 2007, Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products, Cancer Res, 67, 3853, 10.1158/0008-5472.CAN-06-4257 · DOI · Paper page
  89. Kurd, 2008, Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: a prospective clinical trial, J Am Acad Dermatol, 58, 625, 10.1016/j.jaad.2007.12.035 · DOI
  90. Kuroda, 2005, Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice, Biol Pharm Bull, 28, 937, 10.1248/bpb.28.937 · DOI
  91. Kurup, 2008, Immunomodulatory effects of curcumin in allergy, Mol Nutr Food Res, 10.1002/mnfr.200700293 · DOI
  92. Kurup, 2007, Immune response modulation by curcumin in a latex allergy model, Clin Mol Allergy, 5, 1, 10.1186/1476-7961-5-1 · DOI
  93. Lao, 2006, Dose escalation of a curcuminoid formulation, BMC Complement Altern Med, 6, 10, 10.1186/1472-6882-6-10 · DOI
  94. Lev-Ari, 2006, Curcumin synergistically potentiates the growth-inhibitory and pro-apoptotic effects of celecoxib in osteoarthritis synovial adherent cells, Rheumatology (Oxford), 45, 171, 10.1093/rheumatology/kei132 · DOI
  95. Li, 2004, Gout: a review of its aetiology and treatment, Hong Kong Med J, 10, 261
  96. Li, 2008, Curcumin prevents and reverses murine cardiac hypertrophy, J Clin Invest, 118, 879
  97. Li, 2004, Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis, Cancer, 101, 2351, 10.1002/cncr.20605 · DOI · Paper page
  98. Li, 2005, Liposome-encapsulated curcumin: in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis, Cancer, 104, 1322, 10.1002/cncr.21300 · DOI
  99. Liacini, 2003, Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes, Exp Cell Res, 288, 208, 10.1016/S0014-4827(03)00180-0 · DOI · Paper page
  100. Lim, 2001, The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse, J Neurosci, 21, 8370, 10.1523/JNEUROSCI.21-21-08370.2001 · DOI · Paper page
  101. Lin, 2007, Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway, Clin Cancer Res, 13, 3423, 10.1158/1078-0432.CCR-06-3072 · DOI · Paper page
  102. Liote, 2007, Recent developments in crystal-induced inflammation pathogenesis and management, Curr Rheumatol Rep, 9, 243, 10.1007/s11926-007-0039-5 · DOI
  103. Liu, 2006, Immunohistochemical localization of activated Stat3 and hTERT protein in psoriasis vulgaris, Eur J Dermatol, 16, 205
  104. Lopez-Lazaro, 2008, Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent, Mol Nutr Food Res, 10.1002/mnfr.200700238 · DOI
  105. Mach, 2005, Inflammation is a crucial feature of atherosclerosis and a potential target to reduce cardiovascular events, Handb Exp Pharmacol, 697, 10.1007/3-540-27661-0_26 · DOI
  106. Mahesh, 2004, Photo-irradiated curcumin supplementation in streptozotocin-induced diabetic rats: effect on lipid peroxidation, Therapie, 59, 639, 10.2515/therapie:2004110 · DOI
  107. Maiti, 2007, Curcumin-phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats, Int J Pharm, 330, 155, 10.1016/j.ijpharm.2006.09.025 · DOI
  108. Manikandan, 2004, Curcumin modulates free radical quenching in myocardial ischaemia in rats, Int J Biochem Cell Biol, 36, 1967, 10.1016/j.biocel.2004.01.030 · DOI
  109. Marczylo, 2007, Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine, Cancer Chemother Pharmacol, 60, 171, 10.1007/s00280-006-0355-x · DOI
  110. Marwick, 2007, Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC-2 as a therapeutic strategy, Expert Opin Ther Targets, 11, 745, 10.1517/14728222.11.6.745 · DOI
  111. Mazumder, 1995, Inhibition of human immunodeficiency virus type-1 integrase by curcumin, Biochem Pharmacol, 49, 1165, 10.1016/0006-2952(95)98514-A · DOI
  112. McCormick, 2007, Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms, Arterioscler Thromb Vasc Biol, 27, 461, 10.1161/01.ATV.0000257552.94483.14 · DOI · Paper page
  113. Meghana, 2007, Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role, Eur J Pharmacol, 577, 183, 10.1016/j.ejphar.2007.09.002 · DOI
  114. Moller, 2003, Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation, Int J Obes Relat Metab Disord, 27, S17, 10.1038/sj.ijo.0802494 · DOI
  115. Morimoto, 2008, The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats, J Clin Invest, 118, 868
  116. Mrudula, 2007, Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina, Biochem Biophys Res Commun, 361, 528, 10.1016/j.bbrc.2007.07.059 · DOI
  117. Murugan, 2005, Effect of tetrahydrocurcumin on erythromycin estolate-induced lipid peroxidation in rats, J Basic Clin Physiol Pharmacol, 16, 1, 10.1515/JBCPP.2005.16.1.1 · DOI
  118. Murugan, 2006, Effect of tetrahydrocurcumin on lipid peroxidation and lipids in streptozotocin-nicotinamide-induced diabetic rats, Basic Clin Pharmacol Toxicol, 99, 122, 10.1111/j.1742-7843.2006.pto_447.x · DOI
  119. Murugan, 2007, Influence of tetrahydrocurcumin on erythrocyte membrane bound enzymes and antioxidant status in experimental type 2 diabetic rats, J Ethnopharmacol, 113, 479, 10.1016/j.jep.2007.07.004 · DOI
  120. Murugan, 2007, Influence of tetrahydrocurcumin on hepatic and renal functional markers and protein levels in experimental type 2 diabetic rats, Basic Clin Pharmacol Toxicol, 101, 241, 10.1111/j.1742-7843.2007.00109.x · DOI
  121. Mythri, 2007, Mitochondrial complex I inhibition in Parkinson's disease: how can curcumin protect mitochondria?, Antioxid Redox Signal, 9, 399, 10.1089/ars.2006.1479 · DOI
  122. Natarajan, 2002, Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes, J Immunol, 168, 6506, 10.4049/jimmunol.168.12.6506 · DOI
  123. Nirmala, 1996, Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats, Biochem Pharmacol, 51, 47, 10.1016/0006-2952(95)02118-3 · DOI
  124. Nirmala, 1996, Protective role of curcumin against isoproterenol induced myocardial infarction in rats, Mol Cell Biochem, 159, 85, 10.1007/BF00420910 · DOI
  125. Nishiyama, 2005, Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice, J Agric Food Chem, 53, 959, 10.1021/jf0483873 · DOI · Paper page
  126. Odrowaz-Sypniewska, 2007, Markers of pro-inflammatory and pro-thrombotic state in the diagnosis of metabolic syndrome, Adv Med Sci, 52, 246
  127. Olszanecki, 2005, Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice, J Physiol Pharmacol, 56, 627
  128. Ono, 2004, Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro, J Neurosci Res, 75, 742, 10.1002/jnr.20025 · DOI · Paper page
  129. Onodera, 2000, Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis, J Biol Chem, 275, 444, 10.1074/jbc.275.1.444 · DOI · Paper page
  130. Pan, 2007, In vitro studies of platelet adhesion, activation, and protein adsorption on curcumin-eluting biodegradable stent materials, J Biomed Mater Res A, 82, 740, 10.1002/jbm.a.31108 · DOI
  131. Pan, 2007, Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin, Colloids Surf B Biointerfaces, 59, 105, 10.1016/j.colsurfb.2007.04.015 · DOI
  132. Pari, 2007, Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats, Ren Fail, 29, 881, 10.1080/08860220701540326 · DOI
  133. Pari, 2007, Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats, J Med Food, 10, 323, 10.1089/jmf.2006.058 · DOI
  134. Park, 2007, Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis, Int J Mol Med, 20, 365
  135. Parodi, 2006, Oral administration of diferuloylmethane (curcumin) suppresses proinflammatory cytokines and destructive connective tissue remodeling in experimental abdominal aortic aneurysms, Ann Vasc Surg, 20, 360, 10.1007/s10016-006-9054-7 · DOI
  136. Patumraj, 2006, Combined effects of curcumin and vitamin C to protect endothelial dysfunction in the iris tissue of STZ-induced diabetic rats, Clin Hemorheol Microcirc, 35, 481
  137. Pillarisetti, 2004, Role of oxidative stress and inflammation in the origin of Type 2 diabetes—a paradigm shift, Expert Opin Ther Targets, 8, 401, 10.1517/14728222.8.5.401 · DOI
  138. Pol, 2003, Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human keratinocytes, using a simple 96-well-plate assay, In Vitro Cell Dev Biol Anim, 39, 36, 10.1290/1543-706X(2003)039<0036:COAEOE>2.0.CO;2 · DOI
  139. Pugazhenthi, 2007, Regulation of heme oxygenase-1 expression by demethoxy curcuminoids through Nrf2 by a PI3-kinase/Akt-mediated pathway in mouse beta-cells, Am J Physiol Endocrinol Metab, 293, E645, 10.1152/ajpendo.00111.2007 · DOI
  140. Punithavathi, 2000, Curcumin inhibition of bleomycin-induced pulmonary fibrosis in rats, Br J Pharmacol, 131, 169, 10.1038/sj.bjp.0703578 · DOI
  141. Quiles, 1998, An ethanolic-aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits, Biofactors, 8, 51, 10.1002/biof.5520080110 · DOI
  142. Quiles, 2002, Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits, Arterioscler Thromb Vasc Biol, 22, 1225, 10.1161/01.ATV.0000020676.11586.F2 · DOI
  143. Ram, 2003, Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs, Biol Pharm Bull, 26, 1021, 10.1248/bpb.26.1021 · DOI
  144. Ramaswami, 2004, Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries, J Vasc Surg, 40, 1216, 10.1016/j.jvs.2004.09.021 · DOI
  145. Ramirez Boscá, 2000, An hydroalcoholic extract of Curcuma longa lowers the abnormally high values of human-plasma fibrinogen, Mech Ageing Dev, 114, 207, 10.1016/S0047-6374(00)00089-0 · DOI
  146. Ramirez-Tortosa, 1999, Oral administration of a turmeric extract inhibits LDL oxidation and has hypocholesterolemic effects in rabbits with experimental atherosclerosis, Atherosclerosis, 147, 371, 10.1016/S0021-9150(99)00207-5 · DOI
  147. Rao, 1970, Effect of curcumin on serum and liver cholesterol levels in the rat, J Nutr, 100, 1307, 10.1093/jn/100.11.1307 · DOI
  148. Rathore, 2007, Curcuma Oil: Reduces Early Accumulation of Oxidative Product and is Anti-apoptogenic in Transient Focal Ischemia in Rat Brain, Neurochem Res
  149. Riva, 2008, Two immunomodulators, curcumin and sulfasalazine, enhance IDV antiretroviral activity in HIV-1 persistently infected cells, Arch Virol, 153, 561, 10.1007/s00705-007-0023-4 · DOI
  150. Robinson, 2007, Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome, Appl Physiol Nutr Metab, 32, 1008, 10.1139/H07-087 · DOI
  151. Rodriguez-Bores, 2007, Basic and clinical aspects of osteoporosis in inflammatory bowel disease, World J Gastroenterol, 13, 6156, 10.3748/wjg.v13.i46.6156 · DOI
  152. Sajithlal, 1998, Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats, Biochem Pharmacol, 56, 1607, 10.1016/S0006-2952(98)00237-8 · DOI
  153. Sale, 2008, The relationship between disease symptoms, life events, coping and treatment, and depression among older adults with osteoarthritis, J Rheumatol, 35, 335
  154. Salh, 2003, Curcumin attenuates DNB-induced murine colitis, Am J Physiol Gastrointest Liver Physiol, 285, G235, 10.1152/ajpgi.00449.2002 · DOI
  155. Sandur, 2007, Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane), Free Radic Biol Med, 43, 568, 10.1016/j.freeradbiomed.2007.05.009 · DOI
  156. Sandur, 2007, Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism, Carcinogenesis, 28, 1765, 10.1093/carcin/bgm123 · DOI · Paper page
  157. Schlesinger, 2006, Colchicine for acute gout, Cochrane Database Syst Rev, 10.1002/14651858.CD006190 · DOI
  158. Selmi, 2007, Inflammation and oxidative stress in obstructive sleep apnea syndrome, Exp Biol Med (Maywood), 232, 1409, 10.3181/0704-MR-103 · DOI
  159. Sethi, 2008, Nuclear factor-kappaB activation: from bench to bedside, Exp Biol Med (Maywood), 233, 21, 10.3181/0707-MR-196 · DOI · Paper page
  160. Shahed, 2001, Quercetin and curcumin up-regulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury, Transplant Proc, 33, 2988, 10.1016/S0041-1345(01)02283-7 · DOI
  161. Shakibaei, 2005, Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: an immunomorphological study, Ann Anat, 187, 487, 10.1016/j.aanat.2005.06.007 · DOI
  162. Sharma, 2004, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance, Clin Cancer Res, 10, 6847, 10.1158/1078-0432.CCR-04-0744 · DOI · Paper page
  163. Sharma, 2007, Pharmacokinetics and pharmacodynamics of curcumin, Adv Exp Med Biol, 595, 453, 10.1007/978-0-387-46401-5_20 · DOI · Paper page
  164. Sharma, 2007, Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: participation of nitric oxide and TNF-alpha, Phytother Res, 21, 278, 10.1002/ptr.2070 · DOI
  165. Sharma, 2006, Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain, Eur J Pharmacol, 536, 256, 10.1016/j.ejphar.2006.03.006 · DOI
  166. Sharma, 2006, Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats, Clin Exp Pharmacol Physiol, 33, 940, 10.1111/j.1440-1681.2006.04468.x · DOI
  167. Shishodia, 2005, Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma, Biochem Pharmacol, 70, 700, 10.1016/j.bcp.2005.04.043 · DOI
  168. Shoba, 1998, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers, Planta Med, 64, 353, 10.1055/s-2006-957450 · DOI · Paper page
  169. Shoskes, 1998, Effect of bioflavonoids quercetin and curcumin on ischemic renal injury: a new class of renoprotective agents, Transplantation, 66, 147, 10.1097/00007890-199807270-00001 · DOI
  170. Shoskes, 2000, Synergy of mycophenolate mofetil and bioflavonoids in prevention of immune and ischemic injury, Transplant Proc, 32, 798, 10.1016/S0041-1345(00)00987-8 · DOI
  171. Sidhu, 1999, Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice, Wound Repair Regen, 7, 362, 10.1046/j.1524-475X.1999.00362.x · DOI
  172. Sidhu, 1998, Enhancement of wound healing by curcumin in animals, Wound Repair Regen, 6, 167, 10.1046/j.1524-475X.1998.60211.x · DOI · Paper page
  173. Singh, 1995, Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected], J Biol Chem, 270, 24995, 10.1074/jbc.270.42.24995 · DOI
  174. Siwak, 2005, Cancer, 104, 879, 10.1002/cncr.21216 · DOI
  175. Skommer, 2007, Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4, Exp Hematol, 35, 84, 10.1016/j.exphem.2006.09.006 · DOI
  176. Smolen, 2008, The burden of rheumatoid arthritis and access to treatment: a medical overview, Eur J Health Econ, 8, S39, 10.1007/s10198-007-0087-9 · DOI
  177. Smolen, 2008, Strengths and limitations of a systematic review on DMARDs for rheumatoid arthritis, Nat Clin Pract Rheumatol, 10.1038/ncprheum0813 · DOI
  178. Sng, 2006, Histone modifications in kainate-induced status epilepticus, Eur J Neurosci, 23, 1269, 10.1111/j.1460-9568.2006.04641.x · DOI
  179. Somasundaram, 2002, Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer, Cancer Res, 62, 3868
  180. South, 1997, Dietary curcumin enhances antibody response in rats, Immunopharmacol Immunotoxicol, 19, 105, 10.3109/08923979709038536 · DOI
  181. Srinivasan, 1972, Effect of curcumin on blood sugar as seen in a diabetic subject, Indian J Med Sci, 26, 269
  182. Srivastava, 1985, Anti-thrombotic effect of curcumin, Thromb Res, 40, 413, 10.1016/0049-3848(85)90276-2 · DOI
  183. Sumanont, 2006, Prevention of kainic acid-induced changes in nitric oxide level and neuronal cell damage in the rat hippocampus by manganese complexes of curcumin and diacetylcurcumin, Life Sci, 78, 1884, 10.1016/j.lfs.2005.08.028 · DOI
  184. Suryanarayana, 2005, Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats, Invest Ophthalmol Vis Sci, 46, 2092, 10.1167/iovs.04-1304 · DOI
  185. Suryanarayana, 2007, Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocin-induced diabetic rat, Med Sci Monit, 13, BR286
  186. Suzuki, 2005, Elucidation of anti-allergic activities of curcumin-related compounds with a special reference to their anti-oxidative activities, Biol Pharm Bull, 28, 1438, 10.1248/bpb.28.1438 · DOI
  187. Tergaonkar, 2006, NFkappaB pathway: a good signaling paradigm and therapeutic target, Int J Biochem Cell Biol, 38, 1647, 10.1016/j.biocel.2006.03.023 · DOI
  188. Thaloor, 1999, Systemic administration of the NF-kappaB inhibitor curcumin stimulates muscle regeneration after traumatic injury, Am J Physiol, 277, C320, 10.1152/ajpcell.1999.277.2.C320 · DOI
  189. Thiyagarajan, 2004, Neuroprotective effect of curcumin in middle cerebral artery occlusion induced focal cerebral ischemia in rats, Life Sci, 74, 969, 10.1016/j.lfs.2003.06.042 · DOI · Paper page
  190. Thresiamma, 1996, Protective effect of curcumin, ellagic acid and bixin on radiation induced toxicity, Indian J Exp Biol, 34, 845
  191. Tikoo, 2008, Change in post-translational modifications of histone H3, heat-shock protein-27 and MAP kinase p38 expression by curcumin in streptozotocin-induced type I diabetic nephropathy, Br J Pharmacol, 153, 1225, 10.1038/sj.bjp.0707666 · DOI
  192. Tonnesen, 1987, Studies on curcumin and curcuminoids. IX. Investigation of the photobiological activity of curcumin using bacterial indicator systems, J Pharm Sci, 76, 371, 10.1002/jps.2600760506 · DOI
  193. Tourkina, 2004, Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon, Am J Respir Cell Mol Biol, 31, 28, 10.1165/rcmb.2003-0354OC · DOI
  194. Tschape, 2006, Therapeutic perspectives in Alzheimer's disease, Recent Patents CNS Drug Discov, 1, 119, 10.2174/157488906775245354 · DOI
  195. Ukil, 2003, Curcumin, the major component of food flavour turmeric, reduces mucosal injury in trinitrobenzene sulphonic acid-induced colitis, Br J Pharmacol, 139, 209, 10.1038/sj.bjp.0705241 · DOI
  196. Uno, 2006, The role of tumor necrosis factor alpha in down-regulation of osteoblast Phex gene expression in experimental murine colitis, Gastroenterology, 131, 497, 10.1053/j.gastro.2006.05.020 · DOI
  197. Vadhan Raj, 2007, Curcumin downregulates NF-κB and related genes in patients with multiple myeloma: results of a phase1/2 study, American Society of Hematology
  198. Vajragupta, 2005, Active site binding modes of curcumin in HIV-1 protease and integrase, Bioorg Med Chem Lett, 15, 3364, 10.1016/j.bmcl.2005.05.032 · DOI
  199. Vamvouris, 2006, A review of the treatment of psoriasis with infliximab, Rev Recent Clin Trials, 1, 201, 10.2174/157488706778250122 · DOI
  200. Venkatesan, 1998, Curcumin attenuation of acute adriamycin myocardial toxicity in rats, Br J Pharmacol, 124, 425, 10.1038/sj.bjp.0701877 · DOI

200 of 215 shown

Cited by

See all 1,716

Metadata

Authors
Aggarwal, B. B., & Harikumar, K. B.
Venue
The International Journal of Biochemistry & Cell Biology
Publisher
Elsevier BV
Published
2009-01
Volume
41
Issue
1
Pages
40-59
ISSN
1357-2725
DOI
10.1016/j.biocel.2008.06.010
Cited by
1,716
References
9
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.